Inventor · disambiguated record
Axel Rolf Zander
Also filed as: ZANDER AXEL R · ZANDER AXEL ROLF
0 granted patents·7 pending applications·0 citations·filing 2001–2013
Files withLANGE CLAUDIA2ALPHAPTOSE GMBH1RADIOPROTECT ALPHAPTOSE UG HAFTUNGSBESCHRÄNKT & CO KG1UNIVERSITATSKLINIKUM HAMBURG E1ZANDER AXEL R1
Top patents by PatentIndex Score
7 records- 0157US2010136029A1Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological MalignanciesUNIVERSITATSKLINIKUM HAMBURG E·Filed 2007·Application pending·0 cites
- 0251US2013266591A1Use of tri-substituted glycerol compounds for the treatment of hematological malignanciesALPHAPTOSE GMBH·Filed 2013·Application pending·0 cites
- 0337US2007160583A1Method for purifying mesenchymal stem cellsLANGE CLAUDIA·Filed 2004·Application pending·0 cites
- 0430US2014120065A1Protection from lethal irradiation with mesenchymal stromal cellsRADIOPROTECT ALPHAPTOSE UG HAFTUNGSBESCHRÄNKT & CO KG·Filed 2011·Application pending·0 cites
- 0526US2011195497A1Method for purifying mesenchymal stem cellsLANGE CLAUDIA·Filed 2010·Application pending·0 cites
- 0620US2009053809A1Retina-Specific Cells Differentiated In Vitro from Bone Marrow Stem Cells, the Production Thereof and Their UseZANDER AXEL R·Filed 2005·Application pending·0 cites
- 0718US2001039052A1Use of CD34 or a polypeptide derived therefrom as cell-surface/gene transfer markerFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Axel Rolf Zander files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →